the SNP profile using 26 prostate cancer GWAS risk SNPs

Slides:

Advertisements

Similar presentations

Tyrosine kinase signalling (review) TGF signalling Notch signalling.

Advertisements

PCa Screening New Areas of Research Francesco Montorsi Milan.

Evidence for Autosomal Dominant Inheritance of Prostate Cancer

Nat. Rev. Urol. doi: /nrurol

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Figure 4 Types of urinary diversion

Figure 1 Male infertility and assisted reproduction globally

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 2 Recruitment of experts to the Delphi study

Figure 5 Types of urinary diversion

Figure 4 Example of PK/PD simulation to optimize a vinorelbine treatment regimen Figure 4 | Example of PK/PD simulation to optimize a vinorelbine treatment.

Figure 2 Multiscale modelling in oncology

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology

Figure 5 Schematic illustration of different clinical trial designs

Figure 2 Risk factors for sarcopenia

Nat. Rev. Urol. doi: /nrurol

Figure 3 Semantic model of the active surveillance (AS) timeline

Nat. Rev. Urol. doi: /nrurol

Figure 2 Copy-number variations in multiple myeloma

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Representative images from a right radical

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 1 Key elements of the proposed modified Delphi study

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 1 Osteosarcoma epidemiology

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Urol. doi: /nrurol

Figure 2 Schema for the phase II Randomized Observation versus

Figure 1 The development process of the Asian

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Figure 13 Proposed management of bladder cancer with variant histology

Nat. Rev. Urol. doi: /nrurol

Figure 1 Anatomy of the venous drainage from the testes

Figure 3 Treatment algorithm for adult infertile men with varicoceles

Figure 3 Algorithm for the determination of the clinical

Figure 1 Cardiovascular risk and disease across the life-course

Nat. Rev. Urol. doi: /nrurol

Figure 2 Temporal summation

Figure 1 Clinical correlates of neurodegeneration in MS

Figure 6 Image sequence demonstrating coronal cuts on MRI

Figure 3 Genetic pleiotropy in ALS

Nat. Rev. Urol. doi: /nrurol

Figure 3 Template for standard pelvic lymphadenectomy

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 6 The hexosamine biosynthetic pathway (HBP)

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 The evolution of brachytherapy for prostate cancer

Nat. Rev. Urol. doi: /nrurol

Figure 4 The grey zone between active

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Figure 4 Algorithm for when to determine PTEN

Evidence for Autosomal Dominant Inheritance of Prostate Cancer

Comparison of variant associations from previous reports and results from the KP GWAS meta-analysis for 105 known prostate cancer risk SNPs. Plotted values.

Presentation transcript:

the SNP profile using 26 prostate cancer GWAS risk SNPs Figure 2 Predicted cumulative risk of prostate cancer for a 50-year-old male with a positive family history (father with prostate cancer), by percentile of the SNP profile using 26 prostate cancer GWAS risk SNPs Permission obtained from Wiley-Liss © MacInnes, R. J. et al. Genetic Epidemiol. 35, 549–556 (2011) Eeles, R. et al. (2013) The genetic epidemiology of prostate cancer and its clinical implications Nat. Rev. Urol. doi:10.1038/nrurol.2013.266